Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B
Background PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant chang...
Saved in:
Published in | Indian journal of gastroenterology Vol. 32; no. 5; pp. 307 - 310 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
India
Springer India
01.09.2013
|
Subjects | |
Online Access | Get full text |
ISSN | 0254-8860 0975-0711 0975-0711 |
DOI | 10.1007/s12664-013-0334-1 |
Cover
Loading…
Abstract | Background
PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using ‘receiver operating characteristic’ (ROC) plot.
Methods
The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.
Result
The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (
p
< 0.001,
p
< 0.001) and acute viral hepatitis B (
p
< 0.001,
p
< 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).
Conclusion
Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis. |
---|---|
AbstractList | Background
PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using ‘receiver operating characteristic’ (ROC) plot.
Methods
The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.
Result
The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (
p
< 0.001,
p
< 0.001) and acute viral hepatitis B (
p
< 0.001,
p
< 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).
Conclusion
Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis. PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot. The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique. The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986). Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis. PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot.BACKGROUNDPON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot.The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.METHODSThe study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).RESULTThe serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.CONCLUSIONLow PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis. |
Author | Talekar, Swati Jitendra Mogarekar, Mukund Ramchandra |
Author_xml | – sequence: 1 givenname: Mukund Ramchandra surname: Mogarekar fullname: Mogarekar, Mukund Ramchandra email: mrmogarekar@hotmail.com organization: Department of Biochemistry, Swami Ramanand Teerth Rural Government Medical College – sequence: 2 givenname: Swati Jitendra surname: Talekar fullname: Talekar, Swati Jitendra organization: Department of Biochemistry, Swami Ramanand Teerth Rural Government Medical College |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23700138$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtPAyEQx4nR2Id-AC9mj15WB1iW7lEbX0kTEx9nwtKppdlChV0Tv730oSYeemJm8v8B8xuQQ-cdEnJG4ZICyKtIWVkWOVCeA-dFTg9IHyopcpCUHqaaiSIfjUrokUGMC1j3FT8mPcYlJGrUJ88vGLpl1mjTeqcjZtpNMx2-Gowths3AtPbTthZjZl2mG-PnvrEmm-NKt2keN8hfd3NCjma6iXi6O4fk7e72dfyQT57uH8fXk9zwomhzUUMpNdamqpk0JRqtEZkQNZUUZCUlToUAjnTGRC0KYRgy5FVlDBiBU8OH5GJ77yr4jy79Vy1tNNg02qHvoqIFKwFKJiFFz3fRrl7iVK2CXaYl1Y-HFKDbgAk-xoCz3wgFtXattq5VSqu1a0UTI_8xxrZJgndt0LbZS7ItGdMr7h2DWvguuCRrD_QNgAyS5w |
CitedBy_id | crossref_primary_10_3390_vetsci10010033 crossref_primary_10_7759_cureus_46234 crossref_primary_10_1097_MD_0000000000002179 crossref_primary_10_1371_journal_pone_0149207 crossref_primary_10_1186_1746_6148_10_74 crossref_primary_10_1089_omi_2020_0160 crossref_primary_10_1080_01480545_2021_1986061 crossref_primary_10_1016_j_mgene_2013_09_007 crossref_primary_10_1139_bcb_2017_0216 crossref_primary_10_1515_tjb_2018_0156 crossref_primary_10_1016_j_cbi_2023_110563 crossref_primary_10_1017_S0007114515004985 |
Cites_doi | 10.1006/geno.1996.0225 10.1096/fj.00-0650rev 10.1016/j.clinbiochem.2008.09.120 10.1016/S0891-5849(98)00272-X 10.1016/j.jhep.2005.12.018 10.1021/bi047440d 10.1002/jbt.20181 10.1172/JCI1649 10.1111/j.1742-1241.2006.01206..x 10.1007/978-1-4020-6561-3_12 10.4103/1319-3767.61232 10.1016/S0009-9120(99)00056-9 10.1007/978-1-4020-6561-3_1 10.1016/j.clinbiochem.2007.01.020 10.3748/wjg.v11.i46.7351 10.1016/S0022-2275(20)33445-3 10.1093/clinchem/48.2.261 10.1016/S0090-9556(24)15082-9 |
ContentType | Journal Article |
Copyright | Indian Society of Gastroenterology 2013 |
Copyright_xml | – notice: Indian Society of Gastroenterology 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s12664-013-0334-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 0975-0711 |
EndPage | 310 |
ExternalDocumentID | 23700138 10_1007_s12664_013_0334_1 |
Genre | Journal Article |
GroupedDBID | --- -EM 06D 0R~ 0VY 1N0 203 29I 29~ 2CU 2KG 2VQ 2WC 30V 4.4 406 408 40D 53G 5GY 5VS 67Z 8TC 96X AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH AAZMS ABAKF ABDZT ABECU ABFTV ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABXPI ACAOD ACCUX ACGFO ACGFS ACHSB ACKNC ACMDZ ACMLO ACOKC ACPIV ACREN ACZOJ ADBBV ADHHG ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGNC AEGXH AEJHL AEJRE AEMSY AEOHA AEPYU AESKC AETCA AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AIAGR AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AMXSW AMYLF AMYQR ANMIH AOCGG AXYYD BAWUL BGNMA C1A CAG COF CSCUP DDRTE DIK DNIVK DPUIP DU5 E3Z EBLON EBS EIOEI EJD EN4 F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 GX1 H13 HF~ HG6 HMJXF HRMNR HZ~ I0C IKXTQ IWAJR IXC IXD J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- NPVJJ NQJWS NU0 O9- O93 O9I O9J OK1 P2P P9S PT4 R9I RLLFE ROL RSV S1Z S27 S37 S3B SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 T13 TR2 TSG U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W2D W48 WK8 XSB Z45 Z7U Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION OVT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c344t-5b067aebc9b27c6ecaaee255b17107977ed5503e1f25b545c2e2e399cc0c5edc3 |
IEDL.DBID | U2A |
ISSN | 0254-8860 0975-0711 |
IngestDate | Tue Aug 05 11:19:12 EDT 2025 Wed Feb 19 01:56:03 EST 2025 Thu Apr 24 23:07:02 EDT 2025 Wed Aug 20 07:41:13 EDT 2025 Fri Feb 21 02:34:23 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Lactonase Paraoxonase Alcoholic liver disease |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c344t-5b067aebc9b27c6ecaaee255b17107977ed5503e1f25b545c2e2e399cc0c5edc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23700138 |
PQID | 1426006270 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1426006270 pubmed_primary_23700138 crossref_primary_10_1007_s12664_013_0334_1 crossref_citationtrail_10_1007_s12664_013_0334_1 springer_journals_10_1007_s12664_013_0334_1 |
PublicationCentury | 2000 |
PublicationDate | 20130900 2013-9-00 2013-Sep 20130901 |
PublicationDateYYYYMMDD | 2013-09-01 |
PublicationDate_xml | – month: 9 year: 2013 text: 20130900 |
PublicationDecade | 2010 |
PublicationPlace | India |
PublicationPlace_xml | – name: India |
PublicationTitle | Indian journal of gastroenterology |
PublicationTitleAbbrev | Indian J Gastroenterol |
PublicationTitleAlternate | Indian J Gastroenterol |
PublicationYear | 2013 |
Publisher | Springer India |
Publisher_xml | – name: Springer India |
References | Aviram, Rosenblat, Bisgauier, Newton, Primo-Parmo, La Du (CR3) 1998; 101 Billecke, Draganov, Counsell (CR8) 2000; 28 Killic, Aydin, Killic, Erman, Aydin, Celik (CR6) 2005; 11 Kujiraoka, Oka, Ishihara (CR13) 2000; 41 Ferre, Camps, Prats (CR4) 2002; 48 Kedage, Muttigi, Shetty (CR12) 2010; 16 Furlong (CR14) 2008 Aslan, Horoz, Nazligul (CR5) 2008; 62 Khersonsky, Tawfik (CR15) 2005; 44 Marsillach, Ferre, Vila (CR17) 2007; 40 Ferré, Marsillach, Camps (CR19) 2006; 45 Primo-Parmo, Sorenson, Teiber, La Du (CR2) 1996; 33 Tsukamoto, Lu (CR1) 2001; 15 Eckerson, Wyte, LA Du (CR9) 1983; 35 Marsillach, Aragones, Beltran (CR10) 2009; 42 Hill, Devarajan, Joshi-Barve, Barve, McClain (CR11) 1999; 32 Furlong (CR16) 2007; 21 Aviram, Rosenblat, Billecke (CR18) 1999; 26 Marsillach, Parra, Ferré (CR7) 2008 M Aviram (334_CR3) 1998; 101 J Marsillach (334_CR17) 2007; 40 SS Killic (334_CR6) 2005; 11 CE Furlong (334_CR14) 2008 S Billecke (334_CR8) 2000; 28 M Aviram (334_CR18) 1999; 26 M Aslan (334_CR5) 2008; 62 T Kujiraoka (334_CR13) 2000; 41 O Khersonsky (334_CR15) 2005; 44 J Marsillach (334_CR10) 2009; 42 J Marsillach (334_CR7) 2008 V Kedage (334_CR12) 2010; 16 DB Hill (334_CR11) 1999; 32 SL Primo-Parmo (334_CR2) 1996; 33 N Ferre (334_CR4) 2002; 48 H Tsukamoto (334_CR1) 2001; 15 HW Eckerson (334_CR9) 1983; 35 N Ferré (334_CR19) 2006; 45 CE Furlong (334_CR16) 2007; 21 17936934 - J Biochem Mol Toxicol. 2007;21(4):197-205 17887991 - Int J Clin Pract. 2008 Jul;62(7):1050-5 17335791 - Clin Biochem. 2007 Jun;40(9-10):645-50 10614719 - Clin Biochem. 1999 Oct;32(7):563-70 16437641 - World J Gastroenterol. 2005 Dec 14;11(46):7351-4 9541487 - J Clin Invest. 1998 Apr 15;101(8):1581-90 20339175 - Saudi J Gastroenterol. 2010 Apr-Jun;16(2):79-83 11038162 - Drug Metab Dispos. 2000 Nov;28(11):1335-42 11387231 - FASEB J. 2001 Jun;15(8):1335-49 10232833 - Free Radic Biol Med. 1999 Apr;26(7-8):892-904 10946025 - J Lipid Res. 2000 Aug;41(8):1358-63 15835926 - Biochemistry. 2005 Apr 26;44(16):6371-82 11805006 - Clin Chem. 2002 Feb;48(2):261-8 6316781 - Am J Hum Genet. 1983 Nov;35(6):1126-38 16510204 - J Hepatol. 2006 Jul;45(1):51-9 8661009 - Genomics. 1996 May 1;33(3):498-507 18977341 - Clin Biochem. 2009 Jan;42(1-2):91-8 |
References_xml | – volume: 33 start-page: 498 year: 1996 end-page: 507 ident: CR2 article-title: The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family publication-title: Genomics doi: 10.1006/geno.1996.0225 – volume: 11 start-page: 7351 year: 2005 end-page: 7354 ident: CR6 article-title: Serum arylesterase and paraoxonase activity in patients with chronic hepatitis publication-title: World J Gastroenterol – volume: 41 start-page: 1358 year: 2000 end-page: 1363 ident: CR13 article-title: A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration publication-title: J Lipid Res. – volume: 15 start-page: 1335 year: 2001 end-page: 1349 ident: CR1 article-title: Current concepts in the pathogenesis of alcoholic liver injury publication-title: FASEB J doi: 10.1096/fj.00-0650rev – volume: 42 start-page: 91 year: 2009 end-page: 98 ident: CR10 article-title: The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2008.09.120 – volume: 26 start-page: 892 year: 1999 end-page: 904 ident: CR18 article-title: Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(98)00272-X – volume: 28 start-page: 1335 year: 2000 end-page: 1342 ident: CR8 article-title: Human serum paraoxonase (PON1) isozymes Q And R hydrolyze lactones and cyclic carbonate esters publication-title: Drug Metab Dispos – volume: 45 start-page: 51 year: 2006 end-page: 59 ident: CR19 article-title: Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases publication-title: J Hepatol doi: 10.1016/j.jhep.2005.12.018 – volume: 48 start-page: 261 year: 2002 end-page: 268 ident: CR4 article-title: Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage publication-title: Clin Chem – volume: 44 start-page: 6371 year: 2005 end-page: 6382 ident: CR15 article-title: Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase publication-title: Biochemistry doi: 10.1021/bi047440d – volume: 21 start-page: 197 year: 2007 end-page: 205 ident: CR16 article-title: Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.20181 – volume: 35 start-page: 1126 year: 1983 end-page: 1138 ident: CR9 article-title: The human serum paraoxonase/arylesterase polymorphism publication-title: Am J Hum Genet – volume: 101 start-page: 1581 year: 1998 end-page: 1590 ident: CR3 article-title: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase publication-title: J Clin Invest doi: 10.1172/JCI1649 – volume: 62 start-page: 1050 year: 2008 end-page: 1055 ident: CR5 article-title: Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis publication-title: Int J Clin Pract doi: 10.1111/j.1742-1241.2006.01206..x – start-page: 187 year: 2008 end-page: 198 ident: CR7 publication-title: Paraoxonase-1 in chronic liver diseases, neurological diseases, and HIV infection. The paraoxonases: their role in disease development and xenobiotic metabolism doi: 10.1007/978-1-4020-6561-3_12 – volume: 16 start-page: 79 year: 2010 end-page: 83 ident: CR12 article-title: Serum paraoxonase activity status in patients with liver disorders publication-title: Saudi J Gastroenterol doi: 10.4103/1319-3767.61232 – volume: 32 start-page: 563 year: 1999 end-page: 570 ident: CR11 article-title: Antioxidants attenuate nuclear factor-Kappa B activation and tumor necrosis factor-alpha production in alcohol hepatitis patient monocytes and rat Kupffer cells, in vitro publication-title: Clin Biochem doi: 10.1016/S0009-9120(99)00056-9 – start-page: 3 year: 2008 end-page: 31 ident: CR14 publication-title: Paraoxonases: an historical perspective. The paraoxonases: their role in disease development and xenobiotic metabolism doi: 10.1007/978-1-4020-6561-3_1 – volume: 40 start-page: 645 year: 2007 end-page: 650 ident: CR17 article-title: Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2007.01.020 – volume: 32 start-page: 563 year: 1999 ident: 334_CR11 publication-title: Clin Biochem doi: 10.1016/S0009-9120(99)00056-9 – volume: 62 start-page: 1050 year: 2008 ident: 334_CR5 publication-title: Int J Clin Pract doi: 10.1111/j.1742-1241.2006.01206..x – volume: 11 start-page: 7351 year: 2005 ident: 334_CR6 publication-title: World J Gastroenterol doi: 10.3748/wjg.v11.i46.7351 – volume: 15 start-page: 1335 year: 2001 ident: 334_CR1 publication-title: FASEB J doi: 10.1096/fj.00-0650rev – volume: 41 start-page: 1358 year: 2000 ident: 334_CR13 publication-title: J Lipid Res. doi: 10.1016/S0022-2275(20)33445-3 – start-page: 3 volume-title: Paraoxonases: an historical perspective. The paraoxonases: their role in disease development and xenobiotic metabolism year: 2008 ident: 334_CR14 doi: 10.1007/978-1-4020-6561-3_1 – volume: 40 start-page: 645 year: 2007 ident: 334_CR17 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2007.01.020 – volume: 35 start-page: 1126 year: 1983 ident: 334_CR9 publication-title: Am J Hum Genet – volume: 42 start-page: 91 year: 2009 ident: 334_CR10 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2008.09.120 – volume: 45 start-page: 51 year: 2006 ident: 334_CR19 publication-title: J Hepatol doi: 10.1016/j.jhep.2005.12.018 – volume: 101 start-page: 1581 year: 1998 ident: 334_CR3 publication-title: J Clin Invest doi: 10.1172/JCI1649 – start-page: 187 volume-title: Paraoxonase-1 in chronic liver diseases, neurological diseases, and HIV infection. The paraoxonases: their role in disease development and xenobiotic metabolism year: 2008 ident: 334_CR7 doi: 10.1007/978-1-4020-6561-3_12 – volume: 48 start-page: 261 year: 2002 ident: 334_CR4 publication-title: Clin Chem doi: 10.1093/clinchem/48.2.261 – volume: 26 start-page: 892 year: 1999 ident: 334_CR18 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(98)00272-X – volume: 33 start-page: 498 year: 1996 ident: 334_CR2 publication-title: Genomics doi: 10.1006/geno.1996.0225 – volume: 16 start-page: 79 year: 2010 ident: 334_CR12 publication-title: Saudi J Gastroenterol doi: 10.4103/1319-3767.61232 – volume: 21 start-page: 197 year: 2007 ident: 334_CR16 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.20181 – volume: 28 start-page: 1335 year: 2000 ident: 334_CR8 publication-title: Drug Metab Dispos doi: 10.1016/S0090-9556(24)15082-9 – volume: 44 start-page: 6371 year: 2005 ident: 334_CR15 publication-title: Biochemistry doi: 10.1021/bi047440d – reference: 20339175 - Saudi J Gastroenterol. 2010 Apr-Jun;16(2):79-83 – reference: 18977341 - Clin Biochem. 2009 Jan;42(1-2):91-8 – reference: 9541487 - J Clin Invest. 1998 Apr 15;101(8):1581-90 – reference: 8661009 - Genomics. 1996 May 1;33(3):498-507 – reference: 11805006 - Clin Chem. 2002 Feb;48(2):261-8 – reference: 11387231 - FASEB J. 2001 Jun;15(8):1335-49 – reference: 10614719 - Clin Biochem. 1999 Oct;32(7):563-70 – reference: 16510204 - J Hepatol. 2006 Jul;45(1):51-9 – reference: 6316781 - Am J Hum Genet. 1983 Nov;35(6):1126-38 – reference: 15835926 - Biochemistry. 2005 Apr 26;44(16):6371-82 – reference: 11038162 - Drug Metab Dispos. 2000 Nov;28(11):1335-42 – reference: 10232833 - Free Radic Biol Med. 1999 Apr;26(7-8):892-904 – reference: 17936934 - J Biochem Mol Toxicol. 2007;21(4):197-205 – reference: 16437641 - World J Gastroenterol. 2005 Dec 14;11(46):7351-4 – reference: 10946025 - J Lipid Res. 2000 Aug;41(8):1358-63 – reference: 17887991 - Int J Clin Pract. 2008 Jul;62(7):1050-5 – reference: 17335791 - Clin Biochem. 2007 Jun;40(9-10):645-50 |
SSID | ssj0025493 |
Score | 2.0263832 |
Snippet | Background
PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with... PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 307 |
SubjectTerms | Adolescent Adult Aged Alanine Transaminase - blood Alkaline Phosphatase - blood Aryldialkylphosphatase - blood Aspartate Aminotransferases - blood Carboxylic Ester Hydrolases - blood Case-Control Studies Gastroenterology Hepatitis B, Chronic - enzymology Hepatitis, Alcoholic - enzymology Hepatology Humans Medicine Medicine & Public Health Middle Aged Original Article ROC Curve Young Adult |
Title | Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B |
URI | https://link.springer.com/article/10.1007/s12664-013-0334-1 https://www.ncbi.nlm.nih.gov/pubmed/23700138 https://www.proquest.com/docview/1426006270 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA_iQHwRv60fo4JPSqBNk7R7nLI5HfNBHMynkqQpDmYna_fgf-8l_RgyFXwpbUlSuLv0fj_ucofQlQIKQJmSmLJUwyXhWCbMx6knBOUkidKOOTs8euKDMX2csEl1jjuvs93rkKT9U68Ou4EvMRkTAfaCgGKgPC1mqDsY8Zh0G5YFhMeGleEGRxFvQpk_LfHdGa0hzLXoqHU6_V20U6FFt1uqdw9t6GwfbY2qePgBeoatvnx3Z6ZpTgb-yBVZ4orF58zWP7AvlG0PAXzYnWauKBviTpX7pk0qdTHN7ZTV0-0hGvd7L3cDXHVJwCqgtMBMgsMRWqqOJKHiWgmhNRAF6QN4CAHe6QRYSKD9lDAJeEkRTTTAEqU8xXSigiO0mc0zfYJcQCeK-ZJrKn2acICOaZQAiTXqZCkhDvJqccWqKiFuOlnM4lXxYyPhGCQcGwnHvoOumykfZf2MvwZf1jqIwcpN6EJker7MgaCYQvqchJ6DjkvlNMuRILTxVgfd1NqKq42Y__6t03-NPkPbxJqNSS47R5vFYqkvAI0Uso1a3fvXYa8NePxh2La2-AUbDdcL |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA6ioL6Id-s1gk9KoE2Ttnuc4pi67UE22FtJ0hQHs5O1e_Dfe5JehkwFX0pbkhTOSXq-j3ND6EYBBWBcScJ4quGSBEQm3COpKwQLaBKlLZM73B8E3RF7HvNxlced19HutUvS_qmXyW5gS0zEhE9c32cEKM8GYIHIxHGNaLthWUB4rFsZbkgUBY0r86clvhujFYS54h21Rqezi3YqtIjbpXr30JrO9tFmv_KHH6BXOOqLdzw1TXMysEdYZAkW88-prX9gXyjbHgL4MJ5kWJQNcScKv2kTSl1Mcjtl-XR_iEadx-FDl1RdEojyGSsIl2BwhJaqJWmoAq2E0BqIgvQAPIQA73QCLMTXXkq5BLykqKYaYIlSruI6Uf4RWs9mmT5BGNCJ4p4MNJMeSwKAjmmUAIk16uQppQ5ya3HFqiohbjpZTONl8WMj4RgkHBsJx56DbpspH2X9jL8GX9c6iGGXG9eFyPRskQNBMYX0Axq6DjouldMsR_3Q-lsddFdrK64OYv77t07_NfoKbXWH_V7cexq8nKFtareQCTQ7R-vFfKEvAJkU8tLuxC-XENdx |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8NAEF6kQvFFvI1nBJ-UpclmN00f61Hq0SJioW9hr2ChpqVNH_z3zm6OIlXBl5CE3Q3MzGa-j5mdQehSAgWgTApMWaLhokIsFPNx4nFOQ6KipGXODvf6YXdAH4dsWPQ5nZfZ7mVIMj_TYKo0pVljqpLG8uAb-BWTPRFgLwgoBvqzDn9j35j1gLQrxgXkx4aY4QZHUViFNX9a4rtjWkGbK5FS64A6W2izQI5uO1f1NlrT6Q6q94rY-C56hW2_-HDHpoFOCr7J5aly-exzbGsh2BfStooAbuyOUpfnzXFH0n3XJq06G83tlOXTzR4adO7fbru46JiAZUBphpkA58O1kC1BmjLUknOtgTQIH4BEE6CeVsBIAu0nhAnATpJoogGiSOlJppUM9lEtnaT6ELmAVCTzRaip8KkKAUYmkQJCa1TLEkIc5JXiimVRTtx0tRjHy0LIRsIxSDg2Eo59B11VU6Z5LY2_Bl-UOojB4k0Yg6d6spgDWTFF9UPS9Bx0kCunWo4ETRt7ddB1qa242JTz37919K_R56j-cteJnx_6T8dog1gLMjlnJ6iWzRb6FEBKJs6sIX4BRkrbrQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lactonase+and+arylesterase+activities+in+alcoholic+hepatitis+and+hepatitis+B&rft.jtitle=Indian+journal+of+gastroenterology&rft.au=Mogarekar%2C+Mukund+Ramchandra&rft.au=Talekar%2C+Swati+Jitendra&rft.date=2013-09-01&rft.pub=Springer+India&rft.issn=0254-8860&rft.eissn=0975-0711&rft.volume=32&rft.issue=5&rft.spage=307&rft.epage=310&rft_id=info:doi/10.1007%2Fs12664-013-0334-1&rft.externalDocID=10_1007_s12664_013_0334_1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0254-8860&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0254-8860&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0254-8860&client=summon |